SuspendedNot Applicable

Effect of Beginning a Renal Replacement Therapy on Obstructive Sleep Apnea in End Stage Renal Disease Patients

Switzerland30 participantsStarted 2014-03

Plain-language summary

The purpose of this study is to investigate the effect of beginning a renal replacement therapy on fluid overload and its consequence on the severity of obstructive sleep apnea, in patients with end stage chronic kidney disease. It aims further to investigate the relationship between overhydration, nocturnal rostral fluid shift and the severity of sleep apnea.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * moderate to severe obstructive sleep apnea, with an apnea-hypopnea index (AHI) ≥ 15/h * age ≥ 18 years * patient with end stage renal disease without renal replacement therapy. Exclusion Criteria: * unstable congestive heart failure * active psychiatric disease * amputation of the lower limbs, proximal to the ankle

What they're measuring

obstructive sleep apnea severity

Timeframe: six months (before and after beginning of a renal replacement therapy)

Trial details

NCT IDNCT02073344

SponsorCentre Hospitalier Universitaire Vaudois

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11

View on ClinicalTrials.gov More Obstructive Sleep Apnea trials